Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tyramine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Tyramine: Patents, clinical trial progress, indications

Tyramine is an investigational drug.

There have been 16 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Hypercholesterolemia, Hyperlipoproteinemia Type II, and Depressive Disorder. The leading clinical trial sponsors are Sanofi, Regeneron Pharmaceuticals, and New York State Psychiatric Institute.

There are two US patents protecting this investigational drug and twenty-one international patents.

Recent Clinical Trials for Tyramine
A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel SyndromePharmascience Inc.Phase 2
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood PressureBoehringer IngelheimPhase 1
Coenzyme Q10 and Meclofenoxate in Hepatic EncephalopathyZagazig UniversityN/A

See all Tyramine clinical trials

Clinical Trial Summary for Tyramine

Top disease conditions for Tyramine
Top clinical trial sponsors for Tyramine

See all Tyramine clinical trials

US Patents for Tyramine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tyramine   Start Trial Phosphonate compounds for treatment of medical disorders Achillion Pharmaceuticals, Inc. (New Haven, CT)   Start Trial
Tyramine   Start Trial Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Chiesi Farmaceutici S.p.A. (Parma, IT)   Start Trial
Tyramine   Start Trial Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA)   Start Trial
Tyramine   Start Trial Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tyramine

Drugname Country Document Number Estimated Expiration Related US Patent
Tyramine Taiwan 201718611 2035-08-26   Start Trial
Tyramine World Intellectual Property Organization (WIPO) 2017035357 2035-08-26   Start Trial
Tyramine World Intellectual Property Organization (WIPO) 2016033337 2034-08-27   Start Trial
Tyramine Argentina 103666 2035-02-12   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.